The new biobank facility is specially designed for the safe and sustainable storage of biological material such as blood, tissue and synovial fluid. The facility meets national recommendations for safety and storage standards. The biobank has space for up to 35 ultra-freezers.
Good quality
High standards at the biobank ensure high quality biobank material. This makes it possible to participate in national and international projects that strengthen the scope and quality of research.
During the opening, Clinic Manager Kjetil Bergsmark said that the samples stored in the bank give us a unique opportunity to understand diseases at a deeper level. This provides the opportunity to develop new treatment methods and drive innovation in personalized medicine. – By analyzing genetic and biological data, we can create tailored treatments that take into account the needs of the individual, which can lead to more effective therapies and better health for future patients. He thanked everyone involved for their efforts.
Unit manager Line Melå Jacobsen spoke about the assignment the Department of Construction and Technical Operations had received - and how well this had been solved by Mattis Schrøder and his team together with the Unit for Clinical Trials.
Strengthened research and collaboration
Diakonhjemmet is among the country's most active hospitals in clinical research. More and more patients are participating in studies. Many of the studies include storing material in a biobank. Research on this material provides valuable knowledge about biomarkers for efficacy, safety, prognosis and treatment response.
– The biobank initiative and the increased research activity on biological material underline our commitment to improving treatment through new knowledge, says Research Manager Espen A. Haavardsholm.
Here you can find more about the biobank initiative.
International Clinical Trials Day
is celebrated every year on May 20. It is a good opportunity to show extra appreciation for those working in clinical research. They do important work for public health and future treatment.
The date was chosen because James Lind started what is considered the first clinical trial on this very day, in 1747.
Lind included 12 patients in 6 groups, with two patients in each group. The groups received different treatments. He only needed two patients in the group who received two oranges and one lemon daily to find that citrus fruit was a good medicine for scurvy.
Many historians believe that the prevention and treatment of scurvy with citrus fruits was the single most important factor in improving the physical health of the British Navy.
